Trademark Overview
On Wednesday, August 28, 2024, a trademark application was filed for HEFAVAY with the United States Patent and Trademark Office. The USPTO has given the HEFAVAY trademark a serial number of 98721616. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Monday, February 3, 2025. This trademark is owned by GLAXO GROUP LIMITED. The HEFAVAY trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders